Tourmaline Bio
About:
Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve and prevent immune diseases.
Website: https://www.tourmalinebio.com
Top Investors: RA Capital Management, Deep Track Capital, Great Point Partners, Logos Capital, Vivo Capital
Description:
Tourmaline Bio is a clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients and prevent immune diseases.
Total Funding Amount:
$360M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
New York, New York, United States
Founded Date:
2021-01-01
Contact Email:
info(AT)tourmalinebio.com
Founders:
Sandeep Kulkarni
Number of Employees:
11-50
Last Funding Date:
2024-01-25
IPO Status:
Public
© 2025 bioDAO.ai